The data indicated that TGF-β1 promoted EndMT in differentiated-endothelial BCSLCs, which resulted in new blood vessel formation, showing that an important portion of the tumor vascular endothelium came from cancer cells and not from normal endotheliocytes. The gene discussed is TGFB1; the disease is cancer.